國家衛生研究院 NHRI:Item 3990099045/4720
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 853421      在线人数 : 903
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/4720


    题名: TGF-beta-induced Stat3 phosphorylation mediated growth regulation in lungi cancer
    作者: Tseng, SW;Chen, KL;Ho, BY;Shih, NY
    贡献者: National Institute of Cancer Research
    摘要: Background: Transforming growth factor-beta (TGFβ) is a well-known potent growth inhibitor for many tumor cells of epithelial origin. Loss of response to TGFβ-mediated growth inhibition is frequently associated with malignant progression in a variety of human cancers. However, during anticancer chemotherapy, tumor cells often develop a coordinate resistant to that drug and cytotoxic cytokines. Recent study has revealed the cross-resistance of adriamycin and TGFβ in tumor cells. However, no distinct mechanisms have been proposed. Thus, this study tried to dissect the relationship between acquisition of drug resistant of tumor cells and subsequent acquisition of resistance to TGFβ. Materials and methods: NCI-H23 parental (H23P) and NCI-H23 adriamycin resistant (H23ADR) lung adenocarcinoma cell lines were used in this study. The variations of biological functions induced by TGFI3 in these two cell lines were studied by cell proliferation assays, flow cytometric analyses, transcription reporter assays, and Western blotting. Results: We demonstrated that, after TGFβ1 treatment, H23ADR cells are much more refractory to TGFβ-mediated growth suppression than their parental (H23P) cells. The action is not either attributed to differential expression of TGFβ receptors, or involved in TGFβ1-induced cell cycle arrest and cell death between these two cell lines. By comparison studies on differential activations of TGF[Mnduced signaling molecules, we first demonstrate that TGFβ1 can augment endogenous Stat3 activity in H23P cells with slow kinetics, but barely affects on H23ADR cells. Transfection of constitutively active Stat3 into H23ADR cells led to growth suppression in the absence of TGFβ1 ; additionally, expression of dominant-negative Stat3 significantly rescued H23P cells from TGFβ1-mediated growth suppression. Conclusion: Our data suggest that modulation of Stat3 activity play a critical role in the TGFβ1-regulated cell growth during acquired adriamycin resistance, and provide the first evidence that Stat3 activity is involved in the cell growth suppression elicited by TGFβ1 in cancer cells.
    日期: 2005-10
    關聯: EJC Supplements. 2005 Oct;3(2):52.
    Link to: http://dx.doi.org/10.1016/S1359-6349(05)80481-1
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000247564800163
    显示于类别:[施能耀] 會議論文/會議摘要
    [曾思文(1997-2007)] 會議論文/會議摘要

    文件中的档案:

    档案 描述 大小格式浏览次数
    ISI000247564800163.pdf143KbAdobe PDF614检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈